Table 3.
SORL1 ISOFORM | Braak | N | Mean ± SE | P Value* |
Total SORL1 | 0-II | 20 | 2.167 ± 0.150 | 0.009 |
III-V | 8 | 1.507 ± 0.228 | 0.031* | |
VI | 29 | 1.537 ± 0.140 | 0.004* | |
FL-SORL1 | 0-II | 20 | 2.121 ± 0.150 | 0.008 |
III-V | 8 | 1.470 ± 0.222 | 0.031* | |
VI | 29 | 1.493 ± 0.138 | 0.003* | |
Delta-2-SORL1 | 0-II | 20 | 0.046 ± 0.003 | 0.339 |
III-V | 8 | 0.037 ± 0.006 | ||
VI | 29 | 0.044 ± 0.003 | ||
Delta-2-SORL1 (%) | 0-II | 20 | 2.26 ± 0.16 | 0.002 |
III-V | 8 | 2.48 ± 0.15 | 0.454* | |
VI | 29 | 3.02 ± 0.14 | 0.001* |
For each isoform, the initial p value is the overall ANOVA p value, while the p values marked with asterisks refer to LSD post-hoc comparisons with the Braak 0-II group.